Skip to content
Trial Eligibility
Menu

Tier Palliative Care For Patients With Advanced Heart Failure or Cancer

NCT07391956

This study is recruiting at 5 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adaption of the Mount Sinai PALLIATIVE CARE AT HOME (PC@H) program, which delivers home-based palliative care. TIER-PC increases the number and intensity of disciplines added to the patient's care team as their symptoms worsen and function declines. In Tier 1, patients who are able to care for themselves and no/mild symptoms receive a community health worker (CHW) trained to elicit illness understanding in a culturally competent way.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Advanced Heart Failure
  • Advanced Non-Colorectal Gastrointestinal Cancer
  • Advanced Lung Cancer
  • Advanced Triple Negative Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
September 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 5

  • Mount Sinai Queens · Astoria, NY
  • Mount Sinai Downtown · New York, NY
  • Mount Sinai Hospital · New York, NY
  • Mount Sinai Morningside · New York, NY
  • Mount Sinai West · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.